COVID-19: AT LEAST 6 CLINICAL TRIALS UNDERWAY EVALUATING REMEDESIVIR

The US Food and Drug Administration (FDA) issued an update on the progress in developing countermeasures to treat and prevent the novel coronavirus (COVID-19) and contagion live has published news that says there are at least 6 clinical trials underway evaluating Remedesivir. 

Gilead Sciences, an American biotechnology company that researches, develops and commercializes drugs, says it has submitted a request to US FDA to rescind orphan drug designation granted for investigational antiviral for the treatment of COVID-19.